Corcept Therapeutics - 53 Year Dividend History | CORT
Historical dividend payout and yield for Corcept Therapeutics (CORT) since 1971. The current TTM dividend payout for Corcept Therapeutics (CORT) as of November 20, 2024 is $0.00. The current dividend yield for Corcept Therapeutics as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$5.690B |
$0.482B |
|
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
